u/Current_Corner_7431

https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916542

Lilly raised their guidance for the year and also beat their estimates. They have good profit because they sold roughly 2x more than last year, so they compensated for the US price reductions.

Novo is also slightly up. Why? My take is because it's clear from the first 3 months that their pill is a blockbuster and they also haven't lost any market on the injectables.

So hopefully good times ahead!